نتایج جستجو برای: converting enzyme inhibitors

تعداد نتایج: 412663  

Etrat Javadirad Javad Azimivaghar

Introduction: In patients with uncomplicated primary hypertension (HTN), angiotensin converting enzyme inhibitors (ACEIs) are considered as monotherapy. In some studies, cough was not related to age, sex, underlying disease, or drug dosage. However, in previous studies, the incidence of cough was greater in females than males. The aim of this study is to determine the incidence of captopril-ind...

Journal: :Journal of clinical images and medical case reports 2023

Angiotensin-Converting Enzyme Inhibitors (ACEI) are commonly used to prevent cardiac remodeling in patients with ST-Segment Elevation Myocardial Infarction (STEMI).

Journal: :Hypertension 1992
N M Hooper J Hryszko S Y Oppong A J Turner

Several inhibitors of angiotensin converting enzyme were also found to inhibit aminopeptidase P, whereas inhibitors of other mammalian aminopeptidases were ineffective. Aminopeptidase P purified from pig kidney cortex was found to contain one atom of zinc per polypeptide chain, confirming its metalloenzyme nature. The concentrations of converting enzyme inhibitors required to cause 50% inhibiti...

Background and aims: Diabetic nephropathy (DN) is the most common cause of end-stage renal failure which could increase the risk of cardiovascular disease and morbidity and mortality in patients. The aim of this study was to investigate new modalities for treatment of diabetic nephropathy. Methods:This study was a mini-review research to investigate drugs that are used for DN treatment. Resul...

Journal: :Anesthesiology 2017
Pavel S Roshanov Bram Rochwerg Ameen Patel Omid Salehian Emmanuelle Duceppe Emilie P Belley-Côté Gordon H Guyatt Daniel I Sessler Yannick Le Manach Flavia K Borges Vikas Tandon Andrew Worster Alexandra Thompson Mithin Koshy Breagh Devereaux Frederick A Spencer Robert D Sanders Erin N Sloan Erin E Morley James Paul Karen E Raymer Zubin Punthakee P J Devereaux

BACKGROUND The effect on cardiovascular outcomes of withholding angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in chronic users before noncardiac surgery is unknown. METHODS In this international prospective cohort study, the authors analyzed data from 14,687 patients (including 4,802 angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker users) ...

Journal: :Journal of the American College of Cardiology 2001

Journal: :American Journal of Health-System Pharmacy 2000

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید